Riskpilot← Back to searchSign inGet full accessVitavitalis AB
ABActiveOrg 5569741977SkövdeResearch and experimental development on social sciences and humanities · NACE 7220Est. 20140 employees
Revenue 2024
SEK 0
EBITDA margin
—
0% vs 2023
Equity ratio
71.4%
Financial strength
Net profit 2024
SEK -5K
-7% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -1K | +0% |
| Net profit | SEK -5K | -7% |
| Total assets | SEK 2,8M | +0% |
| Equity | SEK 2M | +0% |
| Employees | 0 | — |
Legal name
Vitavitalis AB
Org number
5569741977
Legal form
Aktiebolag
NACE code
7220 · Research and experimental development on social sciences and humanities
Founded
11 juni 2014
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Aktiebolaget ska bedriva utveckling och forskning av metoder samt konsultering inom arbetsförmedling. Utöver det ska bolaget bedriva holdingverksamhet och därmed förenlig verksamhet
Address
Skövde
Email
malek@etvind.nu
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 050 | 1 013 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 2 049 | 1 011 | −12 | −1 | −1 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 2 049 | 1 011 | −12 | −1 | −1 |
| Net financials | −116 | −2 | −4 | −2 | 0 |
| Profit before tax | 1 510 | 756 | −16 | −4 | −1 |
| Tax | −336 | −156 | — | −1 | −4 |
| Net profit | 1 174 | 600 | −16 | −5 | −5 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 823 | 3 269 | 2 918 | 2 758 | 2 756 |
| Equity | 1 394 | 1 994 | 1 977 | 1 973 | 1 967 |
| Long-term debt | 52 | 0 | — | — | — |
| Short-term debt | 855 | 501 | 165 | 10 | 14 |
| Total debt | 907 | 501 | 165 | 10 | 14 |
EBITDA margin
-130000.0%
This company
15.8%
Market median
-822885% vs market
20202024
Equity ratio
71.4%
This company
38.2%
Market median
+87% vs market
20202024
Return on equity
-0.3%
This company
18.4%
Market median
-102% vs market
20202024
Net profit margin
-521100.0%
This company
8.1%
Market median
-6433433% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.40×
This company
0.62×
Market median
+35% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
| Former (1) | ||
| Deputy Board Member | 2020 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Vitavitalis AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lena Marie Malek | Deputy Board Member | 0 companies |
| Paulina Babylonia Yacob | Deputy Board Member | 0 companies |
| Malek Malek | Board of Directors | 0 companies |